Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Replimune Group, Inc. (REPL) Institutional Ownership & Insider Trading

198 institutions reported holding Replimune Group, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 17 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

REPLReplimune Group, Inc.Follow REPL — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

198 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +17.8%.

Increased+70New+68Decreased-42Closed-45

Largest moves, shares (millions)

Ridgeback Capital…+7.3MBoxer Capital Management+2.8MBlackRock+2.7MT. Rowe Price Associates-6.5MFMR-1.1MEcoR1 Capital-1.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-3.3Sep 24+7.9Dec 24+4.2Mar 25-1.1Jun 25-0.5Sep 25+0.1Dec 25+1.4Mar 26+14.4Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2619895+17.8%70684245
Mar 2617981+1.8%60394826
Dec 2516380+0.1%57305129
Sep 2516083-0.6%56334547
Jun 2517481-1.3%46315820
Mar 2516782+5.5%58214312
Dec 2415778+11.6%62233216
Sep 2414370-4.9%55193925

Replimune Group, Inc. — questions

Who owns Replimune Group, Inc. stock?
198 institutions reported Replimune Group, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BAKER BROS. ADVISORS LP (11.7%), BlackRock, Inc. (9.5%), RTW INVESTMENTS, LP (7.9%).
Are Replimune Group, Inc. insiders buying or selling?
17 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Replimune Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.